Global Fund notes that the US has contributed more than $26.31 billion to date and pledged up to $6 billion for the Seventh ...

Only 17,000 Ugandans to benefit from $1.1m Global Fund support as officials warn of high demand for long-acting prevention ...

The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) has announced that it has signed an access agreement with Pharmaceutical Company Gilead Sciences to procure lenacapavir, a ...

HIV incidence and related deaths in sub-Saharan Africa could significantly increase following the suspension of funding for ...

UGANDA: UGANDA’S total number of people living with HIV has surpassed 1.5 million, according to the latest 2024 estimates ...

Lenacapavir is available in both oral tablet form and as subcutaneous injections. It is available as oral tablets and ...

Members of Parliament from the Youth Monitoring Committee, as well as youth health advocates, are calling on the central ...

As Uganda grapples with a resurgence of new HIV infections, we must confront the uncomfortable truth: complacency is our ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

USAID has been present in Uganda for over sixty years. It has funded development in agriculture, education and research in ...

The UNAIDS annual report warns that Trump era HIV funding cuts could lead to 6 million more infections and 4 million deaths ...